Clinical Trial Update: Clinical Trial of Ambroxol in Patients With Type I Gaucher Disease [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial of Ambroxol in Gaucher disease type 1 has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gaucher Disease Type

Drugs mentioned

• Ambroxol (Ambroxol)

Snippet

Sponsor: Exsar Corporation | Conditions: Type I Gaucher Disease | Phase 1, Phase 2 | Status: SUSPENDED